Suppr超能文献

九种量表比较用于帕金森病抑郁的检测:哪种量表更适用?

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

机构信息

Food and Drug Administration, Silver Spring, MD, USA.

出版信息

Neurology. 2012 Mar 27;78(13):998-1006. doi: 10.1212/WNL.0b013e31824d587f. Epub 2012 Mar 14.

Abstract

OBJECTIVE

The Methods of Optimal Depression Detection in Parkinson's Disease (MOOD-PD) study compared the psychometric properties of 9 depression scales to provide guidance on scale selection in Parkinson disease (PD).

METHODS

Patients with PD (n = 229) from community-based neurology practices completed 6 self-report scales (Beck Depression Inventory [BDI]-II, Center for Epidemiologic Studies Depression Rating Scale-Revised [CESD-R], 30-item Geriatric Depression Scale [GDS-30], Inventory of Depressive Symptoms-Patient [IDS-SR], Patient Health Questionnaire-9 [PHQ-9], and Unified Parkinson's Disease Rating Scale [UPDRS]-Part I) and were administered 3 clinician-rated scales (17-item Hamilton Depression Rating Scale [HAM-D-17], Inventory of Depressive Symptoms-Clinician [IDS-C], and Montgomery-Åsberg Depression Rating Scale [MADRS] and a psychiatric interview. DSM-IV-TR diagnoses were established by an expert panel blinded to the self-reported rating scale data. Receiver operating characteristic curves were used to estimate the area under the curve (AUC) of each scale.

RESULTS

All scales performed better than chance (AUC 0.75-0.85). Sensitivity ranged from 0.66 to 0.85 and specificity ranged from 0.60 to 0.88. The UPDRS Depression item had a smaller AUC than the BDI-II, HAM-D-17, IDS-C, and MADRS. The CESD-R also had a smaller AUC than the MADRS. The remaining AUCs were statistically similar.

CONCLUSIONS

The GDS-30 may be the most efficient depression screening scale to use in PD because of its brevity, favorable psychometric properties, and lack of copyright protection. However, all scales studied, except for the UPDRS Depression, are valid screening tools when PD-specific cutoff scores are used.

摘要

目的

最优抑郁检测在帕金森病中的方法(MOOD-PD)研究比较了 9 种抑郁量表的心理计量学特性,为帕金森病(PD)中的量表选择提供指导。

方法

来自社区神经病学实践的 PD 患者(n=229)完成了 6 种自我报告量表(贝克抑郁量表[BDI-II]、复发性流行病学研究抑郁评定量表修订版[CESD-R]、30 项老年抑郁量表[GDS-30]、抑郁症状量表患者版[IDS-SR]、患者健康问卷-9[PHQ-9]和统一帕金森病评定量表[UPDRS]-I),并接受了 3 种临床医生评定量表(17 项汉密尔顿抑郁评定量表[HAM-D-17]、抑郁症状量表临床医生版[IDS-C]和蒙哥马利-Åsberg 抑郁评定量表[MADRS]和精神科访谈)。DSM-IV-TR 诊断由对自我报告评定量表数据盲法的专家小组确定。使用受试者工作特征曲线来估计每个量表的曲线下面积(AUC)。

结果

所有量表的表现均优于随机水平(AUC 0.75-0.85)。敏感性范围为 0.66 至 0.85,特异性范围为 0.60 至 0.88。UPDRS 抑郁项的 AUC 小于 BDI-II、HAM-D-17、IDS-C 和 MADRS。CESD-R 的 AUC 也小于 MADRS。其余 AUC 在统计学上相似。

结论

GDS-30 可能是 PD 中使用最有效的抑郁筛查量表,因为它简短、具有良好的心理计量学特性且无版权保护。然而,当使用 PD 特定的截断分数时,除了 UPDRS 抑郁项外,所有研究的量表都是有效的筛查工具。

相似文献

1
A comparison of nine scales to detect depression in Parkinson disease: which scale to use?
Neurology. 2012 Mar 27;78(13):998-1006. doi: 10.1212/WNL.0b013e31824d587f. Epub 2012 Mar 14.
2
Depression rating scales in Parkinson's disease: critique and recommendations.
Mov Disord. 2007 Jun 15;22(8):1077-92. doi: 10.1002/mds.21333.
3
Depression rating scales in Parkinson's disease: A critical review updating recent literature.
J Affect Disord. 2015 Sep 15;184:216-24. doi: 10.1016/j.jad.2015.05.059. Epub 2015 Jun 10.
4
Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.
Am J Geriatr Psychiatry. 2018 Jun;26(6):700-710. doi: 10.1016/j.jagp.2018.01.005. Epub 2018 Jan 31.
5
What is the best screening test for depression in chronic spinal pain patients?
Spine J. 2014 Jul 1;14(7):1175-82. doi: 10.1016/j.spinee.2013.10.037. Epub 2013 Nov 10.
7
Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale.
Arq Neuropsiquiatr. 2006 Jun;64(2B):407-11. doi: 10.1590/s0004-282x2006000300011.
8
The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease.
Int J Geriatr Psychiatry. 2000 Jul;15(7):644-9. doi: 10.1002/1099-1166(200007)15:7<644::aid-gps167>3.0.co;2-l.
10
Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?
J Affect Disord. 2018 Jan 1;225:449-452. doi: 10.1016/j.jad.2017.08.024. Epub 2017 Aug 15.

引用本文的文献

1
Study Protocol: Investigating the Effects of Transcranial Pulse Stimulation in Parkinson's Disease.
Bioengineering (Basel). 2025 Jul 17;12(7):773. doi: 10.3390/bioengineering12070773.
2
Association between serum myeloperoxidase enzyme activity and Parkinson's disease status.
NPJ Parkinsons Dis. 2025 Apr 26;11(1):94. doi: 10.1038/s41531-025-00941-0.
3
Association of Hemispheric Asymmetry of Dopamine-Transporter Binding with Risk of Parkinsonian Depression.
Mov Disord Clin Pract. 2025 Mar;12(3):302-312. doi: 10.1002/mdc3.14276. Epub 2024 Nov 20.
4
Improving Parkinson's Disease Care through Systematic Screening for Depression.
Mov Disord Clin Pract. 2024 Oct;11(10):1212-1222. doi: 10.1002/mdc3.14163. Epub 2024 Jul 19.
5
Behind the Mask: Parkinson's Disease and Depression.
Cureus. 2024 Jan 21;16(1):e52663. doi: 10.7759/cureus.52663. eCollection 2024 Jan.
7
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease.
Neurol Sci. 2023 May;44(5):1607-1612. doi: 10.1007/s10072-023-06619-w. Epub 2023 Jan 18.
9
Classification of Parkinson's disease motor phenotype: a machine learning approach.
J Neural Transm (Vienna). 2022 Dec;129(12):1447-1461. doi: 10.1007/s00702-022-02552-y. Epub 2022 Nov 6.
10
Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.
Drugs Aging. 2022 Jun;39(6):417-439. doi: 10.1007/s40266-022-00942-1. Epub 2022 Jun 16.

本文引用的文献

1
Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease.
Parkinsonism Relat Disord. 2011 Jan;17(1):40-5. doi: 10.1016/j.parkreldis.2010.10.007. Epub 2010 Nov 17.
3
Screening for depression in adult patients in primary care settings: a systematic evidence review.
Ann Intern Med. 2009 Dec 1;151(11):793-803. doi: 10.7326/0003-4819-151-11-200912010-00007.
5
The impact of depressive symptoms in early Parkinson disease.
Neurology. 2007 Jul 24;69(4):342-7. doi: 10.1212/01.wnl.0000268695.63392.10. Epub 2007 Jun 20.
6
Depression rating scales in Parkinson's disease: critique and recommendations.
Mov Disord. 2007 Jun 15;22(8):1077-92. doi: 10.1002/mds.21333.
7
Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale.
Arq Neuropsiquiatr. 2006 Jun;64(2B):407-11. doi: 10.1590/s0004-282x2006000300011.
8
Validity of the 30-item geriatric depression scale in patients with Parkinson's disease.
Mov Disord. 2006 Oct;21(10):1618-22. doi: 10.1002/mds.21023.
9
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.
Am J Geriatr Psychiatry. 2006 Feb;14(2):169-75. doi: 10.1097/01.JGP.0000192488.66049.4b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验